Based on our previously published study, this treatment protocol maintained the activities of plasma adenosine deaminase and vascular ecto‐adenosine deaminase at level lower than 20% throughout the duration of the experiment.16 4T1 cancer cell implantation and dCF treatment did not affect mouse weight (Figure S1). This evidence concerns the gene ADA and cancer.